HAL-MPE1 Safety and Tolerability Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edwin Kim, MD
UNC Rheumatolory Allergy & Immunology Clinic
Principal Investigator - Robert Wood, MD
John Hopkins Hospital Unversity-Divison of Pediatric Allergy
Principal Investigator - Scott Sicherer, MD
Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Inflamax Research Limited
Mississauga, Ontario, Canada
- John Hopkins Hospital University-Divison of Pediatric Allergy
Baltimore, Maryland, United States
- Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Unc Rheumatolory Allergy & Immunology Clinic
Chapel Hill, North Carolina, United States
- Allergy, Asthma and Immunology Center
Tulsa, Oklahoma, United States
- South Texas Allergy & Asthma Medical Professionals (staamp)
San Antonio, Texas, United States
- Asthma, Inc.
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2016
- Primary completion
- 30 Apr 2019
- Completion
- 30 Sept 2019
- Last update posted
- 19 Feb 2020
- Registered enrollment
- 42
- Registry id
- NCT02991885
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.